# Lycia Therapeutics

**Canonical:** https://apis.io/providers/lycia-therapeutics/  
**Website:** https://lyciatx.com/  
**APIs profiled:** 0

Lycia Therapeutics is a South San Francisco, California biotechnology company developing a new class of targeted protein degradation medicines built on its proprietary lysosomal targeting chimera (LYTAC) platform, which originated in the Stanford University laboratory of Nobel laureate Carolyn Bertozzi, Ph.D. LYTAC molecules bind a disease-driving extracellular protein and shuttle it into the cell for destruction by the lysosome, allowing Lycia to pursue circulating and membrane-bound proteins that conventional small molecules and antibodies have been unable to drug. The company is led by President and Chief Executive Officer Aetna Wun Trombley, Ph.D., is backed by Versant Ventures, Redmile Group, Venrock, RTW and Blue Owl among others, and has partnered with Eli Lilly and Company to discover and develop LYTAC degraders. Lycia is a privately held, research-stage therapeutics company; it publishes no public developer program, API, or machine-readable API artifacts.

## Kin Score — 10.3 / 100 (minimal)

Scored 2026-08-19 under rubric 0.12.0. Trend: flat (-1.2 from 11.5).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Lycia Therapeutics Domain Security** — TLSv1.3

## Tags

Company, Biotechnology, Therapeutics, Drug Discovery, Protein Degradation, Life Sciences, Healthcare, Pharmaceuticals

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/lycia-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.